Clinical trials are more complex and require greater laboratory expertise than ever before. To support your drug development challenges, our scientists bring experience that spans translational biomarker development, flow cytometry, anatomic pathology and histology, vaccines, immunology, and multiple other disciplines.
Take on complex biomarker and advanced cytometric challenges through an extensive flow cytometry offering, spanning complex/translational biomarkers, mass cytometry, and use at clinical trial scale for primary, secondary or experimental endpoints.
Guide your decision-making from discovery to the clinic with exploratory biomarker insights from our Translational Biomarker Solutions (TBS). From initial feasibility and development to advanced validation, testing and production, the experienced TBS team offers collaborative support and fit-for-purpose assays using a diverse toolbox of platforms. Personalized biomarker support is also available to help drive your development from bench to commercialization.
Quality laboratory management made easy. ELMS manages third-party laboratory performance with a rigorous identification, qualification, monitoring and reporting plan to ensure high quality and actionable data. The ELMS team will also support esoteric testing through LabCorp’s Specialty Testing Group, a distinctive combination of specialty laboratories offering discrete esoteric testing capabilities and expertise.
APH laboratories located strategically around the world—many co-located within our global network of central labs—employ innovative technologies, such as digital pathology or multiplex IHC to unlock and analyze scientific insights.
Measure and follow biomarkers, hormones, specific antibodies or viral markers in urine, serum or plasma to gain insights to patient response to therapeutic interventions. We offer a specialized, dedicated vaccine team and a purpose-built vaccines and novel immunotherapeutics laboratory to deliver support for vaccine development – from biomarker discovery and assay development to clinical testing in seasonal or multi-year global studies.